Early eye injection trial for blindness disease finds no vision boost
NCT ID NCT02556736
Summary
This early-stage study tested the safety of a single injection into the eye for people with advanced retinitis pigmentosa, a genetic disease that causes severe vision loss. It involved 14 adults with very poor vision to see if the treatment was safe and tolerable at different doses. The main goal was to check for serious side effects, and the study did not demonstrate that the treatment improved vision.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED RETINITIS PIGMENTOSA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Eye Institute- Edgewood /ID# 236713
Edgewood, Kentucky, 41017-3415, United States
-
Duke Eye Center /ID# 235715
Durham, North Carolina, 27705, United States
-
Retina Foundation of the Southwest /ID# 235199
Dallas, Texas, 75231, United States
-
University of California San Francisco - Mission Bay /ID# 235717
San Francisco, California, 94158, United States
Conditions
Explore the condition pages connected to this study.